Patricia A. Bradford - Apr 27, 2022 Form 3 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
Caitlin Kontulis, attorney-in-fact
Stock symbol
PHIO
Transactions as of
Apr 27, 2022
Transactions value $
$0
Form type
3
Date filed
4/29/2022, 06:00 PM
Next filing
Sep 26, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.